Tyco Healthcare
This article was originally published in The Gray Sheet
Executive Summary
Tyco unit "is driven by consumables, which makes it extremely stable regardless of the economic environment," CEO Dennis Kozlowski says in April 25 letter to shareholders announcing that the conglomerate has terminated plans to break up the company. Tyco originally announced its intention to split into four separate companies - Healthcare, Security and Electronics, Fire Protection and Flow Control, and Financial Services - in order to increase the value of the firms' stock price and provide increased visibility to investors (1"The Gray Sheet" Jan. 28, 2002, p. 3). Wall Street reacted negatively to the plan, however; the company's stock price has dropped from $45 prior to the announced break-up plan to the $20-range...
You may also be interested in...
Tyco Break-Up Positions Health Unit Among Largest U.S. Device Companies
The success of Tyco Healthcare as a stand-alone entity following its spin-off from parent Tyco International may hinge on its ability to continue to move beyond commodity disposable medical products into higher-margin medical device markets
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.